IM Cannabis Regains Compliance with Nasdaq Minimum Bid Price Requirement
Why now
Thesis: Listing compliance fix, no broader signal
Catalyst to watch: Future bid-price or financial compliance
Main risk: Price could fall below threshold again
Why it matters
Regaining Nasdaq bid-price compliance removes delisting overhang for a micro-cap cannabis firm; no sector-wide effect.
Details
VANCOUVER and GLIL YAM, Israel, Sept. 23, 2026 /PRNewswire/ -- IM Cannabis Corp. ("IMC" or the "Company") (Nasdaq: IMCC), a medical cannabis company with operations in Israel and Germany, today announced that on September 23, 2026, it received written notice from Nasdaq Stock Market LLC...
Sources
- prnewswire · 2026-09-23 20:01 UTC